3 Millionaire-Maker Artificial Intelligence (AI) Stocks to Buy Now

AI infrastructure bottleneck winners: Astera Labs posted Q1 2026 revenue of $308.4M (+93% YoY) with 76.3% gross margin and management expects Scorpio to become its largest product line, targeting a $20B 2030 scale-up networking market. Credo Technology’s fiscal Q2 2026 revenue rose to $268M (+272% YoY) and guided for full-year growth above 200%, but with four hyperscalers each >10% of revenue creating valuation and concentration risk. Vertiv highlighted a $15B backlog with a 2.9 book-to-bill ratio and expanding liquid cooling capacity by 40%-50% to address lead times that stretched to 20-26 weeks.

Analysis

Near-term, the cleanest beneficiary is VRT: it monetizes the AI capex cycle through installed-base scarcity, and backlog converts into revenue with less product-cycle risk than the pure interconnect names. ALAB and CRDO can keep working in momentum windows, but they are more exposed to valuation de-rating if hyperscaler procurement shifts from urgency to optimization; that typically shows up first in order cadence, not headline growth.

The second-order winner set extends beyond the names in the article: GPU vendors and hyperscaler builders still need more of VRT's power/cooling stack than the networking layer, so VRT has the broadest capture of incremental spend. By contrast, ALAB/CRDO face a classic merchant-component risk: once one architecture standard wins, pricing power can compress faster than unit growth, especially if large customers internalize designs or dual-source more aggressively.

The key catalyst path is 1-3 months: earnings revisions, backlog conversion, and any commentary on lead-time normalization. Over 6-18 months, the question is whether AI build-out remains a shortage-driven market or shifts into a more competitive, procurement-driven market; that transition would favor VRT over ALAB/CRDO. The contrarian view is that the market may be overpaying for the most visible growth rates while underpricing the durability of the more boring bottleneck supplier.

Falsifiers: a slowdown in hyperscaler capex, flattening backlog/book-to-bill, or any sign that ALAB/CRDO customer concentration is translating into weaker gross margin or lower new-design wins.

Key Decisions for Investors

• Long VRT on pullbacks over the next 1-3 weeks; use earnings/backlog conversion as the confirming catalyst. Risk/reward favors 15-20% upside vs high-single-digit downside if order momentum holds.
• Pair trade: long VRT / short ALAB into strength. Thesis: VRT has broader revenue durability and lower customer-concentration risk; ALAB is more exposed to multiple compression if AI networking growth decelerates. Reassess if ALAB keeps >70% gross margin and raises guidance.
• Avoid chasing CRDO after vertical moves; prefer waiting for a 10-15% drawdown or a post-earnings reset before initiating. The setup is good, but concentration risk makes upside less symmetrical than the growth rate implies.
• If already long ALAB or CRDO, buy downside protection into the next earnings window rather than adding outright. The cleanest hedge is a short VRT/long ALAB relative-value pair unwind only if VRT backlog growth stalls.